Work

Anti-VEGF Antibody HuMV833: an EORTC Biological Treatment Development Group Phase I Toxicity, Pharmacokinetic and Pharmacodynamic Study.

Year: 2001

Type: conference-paper

Source: Research Explorer (The University of Manchester)

Authors: Gordon C. Jayson, C Mulatero, Malcolm Ranson, Jamal Zweit, D. L. Hastings, PJ Julyan, Jeremy Lawrance, AT McGown, Anna Jackson, Hamied Haroon, L. Hakannson, John Wagstaff, Gerard Groenewegen, F.F. Lehmann, Dan Levitt, Tiffany Tang, H. Zweirzina

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2574518933

FWCI: 15.87

Cites:

Cited by: 19

Related to: 10